ALHC vs. GL, KNSL, BNT, BNRE, VOYA, JXN, ESNT, FG, ACT, and BWIN
Should you be buying Alignment Healthcare stock or one of its competitors? The main competitors of Alignment Healthcare include Globe Life (GL), Kinsale Capital Group (KNSL), Brookfield Wealth Solutions (BNT), Brookfield Reinsurance (BNRE), Voya Financial (VOYA), Jackson Financial (JXN), Essent Group (ESNT), F&G Annuities & Life (FG), Enact (ACT), and The Baldwin Insurance Group (BWIN). These companies are all part of the "insurance" industry.
Alignment Healthcare vs.
Alignment Healthcare (NASDAQ:ALHC) and Globe Life (NYSE:GL) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, dividends, community ranking, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.
Globe Life has higher revenue and earnings than Alignment Healthcare. Alignment Healthcare is trading at a lower price-to-earnings ratio than Globe Life, indicating that it is currently the more affordable of the two stocks.
In the previous week, Alignment Healthcare had 9 more articles in the media than Globe Life. MarketBeat recorded 27 mentions for Alignment Healthcare and 18 mentions for Globe Life. Globe Life's average media sentiment score of 1.05 beat Alignment Healthcare's score of 0.64 indicating that Globe Life is being referred to more favorably in the news media.
86.2% of Alignment Healthcare shares are owned by institutional investors. Comparatively, 81.6% of Globe Life shares are owned by institutional investors. 6.6% of Alignment Healthcare shares are owned by insiders. Comparatively, 1.5% of Globe Life shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Alignment Healthcare presently has a consensus target price of $14.83, indicating a potential downside of 15.67%. Globe Life has a consensus target price of $135.60, indicating a potential upside of 4.51%. Given Globe Life's stronger consensus rating and higher possible upside, analysts clearly believe Globe Life is more favorable than Alignment Healthcare.
Globe Life received 6 more outperform votes than Alignment Healthcare when rated by MarketBeat users. However, 63.54% of users gave Alignment Healthcare an outperform vote while only 39.88% of users gave Globe Life an outperform vote.
Globe Life has a net margin of 18.53% compared to Alignment Healthcare's net margin of -5.84%. Globe Life's return on equity of 22.32% beat Alignment Healthcare's return on equity.
Alignment Healthcare has a beta of 1.49, suggesting that its stock price is 49% more volatile than the S&P 500. Comparatively, Globe Life has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500.
Summary
Globe Life beats Alignment Healthcare on 12 of the 18 factors compared between the two stocks.
Get Alignment Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for ALHC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alignment Healthcare Competitors List
Related Companies and Tools
This page (NASDAQ:ALHC) was last updated on 3/25/2025 by MarketBeat.com Staff
Buy ALHC Stock Free ALHC Stock Alerts